J D Newton1, I B Squire. 1. University of Leicester Department of Cardiovascular Sciences, Leicester Royal Infirmary, Leicester, UK.
Abstract
OBJECTIVE: To examine the relationship with outcome of plasma haemoglobin and glucose concentrations, measured soon after first hospital admission with chronic heart failure (CHF), in standard clinical practice. METHODS AND RESULTS: Hospital records of 528 patients (43% women, mean age 70 years) with first hospital admission for CHF were reviewed. During follow up (mean 1257 days, range 520-1800), 240 (45%) patients died. On admission, 140 of 528 (27%) and at discharge 179 of 472 survivors (38%) were receiving treatment for diabetes. World Health Organization criteria for anaemia were met by 39% of men and 43% of women. Lower haemoglobin (hazard ratio 0.879, 95% confidence interval (CI) 0.828 to 0.933, p < 0.0001) and higher plasma glucose (hazard ratio 1.034, 95% CI 1.008 to 1.061, p = 0.009) had univariate association with all-cause mortality. On multivariate analysis, compared with patients with a normal haemoglobin for their sex, hazard ratio was 1.415 (95% CI 1.087 to 1.841, p = 0.010) for those with low haemoglobin. All-cause mortality fell linearly for haemoglobin up to 159 g/l, above which mortality increased. Glucose above the highest quartile (> 10 mmol/l) was an independent predictor of mortality (hazard ratio 1.966, 95% CI 1.376 to 2.810, p = 0.0002). In survivors of the index admission the association between glucose and mortality was linear, the relationship being stronger for patients without diabetes. CONCLUSIONS: Lower haemoglobin and higher plasma glucose are associated with all-cause mortality in CHF. Higher glucose is associated with mortality irrespective of diabetic status.
OBJECTIVE: To examine the relationship with outcome of plasma haemoglobin and glucose concentrations, measured soon after first hospital admission with chronic heart failure (CHF), in standard clinical practice. METHODS AND RESULTS: Hospital records of 528 patients (43% women, mean age 70 years) with first hospital admission for CHF were reviewed. During follow up (mean 1257 days, range 520-1800), 240 (45%) patients died. On admission, 140 of 528 (27%) and at discharge 179 of 472 survivors (38%) were receiving treatment for diabetes. World Health Organization criteria for anaemia were met by 39% of men and 43% of women. Lower haemoglobin (hazard ratio 0.879, 95% confidence interval (CI) 0.828 to 0.933, p < 0.0001) and higher plasma glucose (hazard ratio 1.034, 95% CI 1.008 to 1.061, p = 0.009) had univariate association with all-cause mortality. On multivariate analysis, compared with patients with a normal haemoglobin for their sex, hazard ratio was 1.415 (95% CI 1.087 to 1.841, p = 0.010) for those with low haemoglobin. All-cause mortality fell linearly for haemoglobin up to 159 g/l, above which mortality increased. Glucose above the highest quartile (> 10 mmol/l) was an independent predictor of mortality (hazard ratio 1.966, 95% CI 1.376 to 2.810, p = 0.0002). In survivors of the index admission the association between glucose and mortality was linear, the relationship being stronger for patients without diabetes. CONCLUSIONS: Lower haemoglobin and higher plasma glucose are associated with all-cause mortality in CHF. Higher glucose is associated with mortality irrespective of diabetic status.
Authors: M R Cowie; A Mosterd; D A Wood; J W Deckers; P A Poole-Wilson; G C Sutton; D E Grobbee Journal: Eur Heart J Date: 1997-02 Impact factor: 29.983
Authors: Rakesh Sharma; Darrel P Francis; Bertram Pitt; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker Journal: Eur Heart J Date: 2004-06 Impact factor: 29.983
Authors: K Malmberg; L Rydén; S Efendic; J Herlitz; P Nicol; A Waldenström; H Wedel; L Welin Journal: J Am Coll Cardiol Date: 1995-07 Impact factor: 24.094
Authors: Inder Anand; John J V McMurray; James Whitmore; Marshelle Warren; Anh Pham; Mark A McCamish; Paul B J Burton Journal: Circulation Date: 2004-06-21 Impact factor: 29.690
Authors: Nathaniel Mark Hawkins; Mark C Petrie; Pardeep S Jhund; George W Chalmers; Francis G Dunn; John J V McMurray Journal: Eur J Heart Fail Date: 2009-02 Impact factor: 15.534
Authors: Osnat Itzhaki Ben Zadok; Ran Kornowski; Ilan Goldenberg; Robert Klempfner; Yoel Toledano; Yitschak Biton; Enrique Z Fisman; Alexander Tenenbaum; Gregory Golovchiner; Ehud Kadmon; Alexander Omelchenko; Tuvia Ben Gal; Alon Barsheshet Journal: Cardiovasc Diabetol Date: 2017-08-14 Impact factor: 9.951